414 related articles for article (PubMed ID: 28870657)
1. Use of Biologic Therapy by Pregnant Women With Inflammatory Bowel Disease Does Not Affect Infant Response to Vaccines.
Beaulieu DB; Ananthakrishnan AN; Martin C; Cohen RD; Kane SV; Mahadevan U
Clin Gastroenterol Hepatol; 2018 Jan; 16(1):99-105. PubMed ID: 28870657
[TBL] [Abstract][Full Text] [Related]
2. Exposure Concentrations of Infants Breastfed by Women Receiving Biologic Therapies for Inflammatory Bowel Diseases and Effects of Breastfeeding on Infections and Development.
Matro R; Martin CF; Wolf D; Shah SA; Mahadevan U
Gastroenterology; 2018 Sep; 155(3):696-704. PubMed ID: 29857090
[TBL] [Abstract][Full Text] [Related]
3. Elevated levels of maternal anti-tetanus toxin antibodies do not suppress the immune response to a Haemophilus influenzae type b polyribosylphosphate-tetanus toxoid conjugate vaccine.
Panpitpat C; Thisyakorn U; Chotpitayasunondh T; Fürer E; Que JU; Hasler T; Cryz SJ
Bull World Health Organ; 2000; 78(3):364-71. PubMed ID: 10812736
[TBL] [Abstract][Full Text] [Related]
4. Concentrations of Adalimumab and Infliximab in Mothers and Newborns, and Effects on Infection.
Julsgaard M; Christensen LA; Gibson PR; Gearry RB; Fallingborg J; Hvas CL; Bibby BM; Uldbjerg N; Connell WR; Rosella O; Grosen A; Brown SJ; Kjeldsen J; Wildt S; Svenningsen L; Sparrow MP; Walsh A; Connor SJ; Radford-Smith G; Lawrance IC; Andrews JM; Ellard K; Bell SJ
Gastroenterology; 2016 Jul; 151(1):110-9. PubMed ID: 27063728
[TBL] [Abstract][Full Text] [Related]
5. Maternal immunization with Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine in The Gambia.
Mulholland K; Suara RO; Siber G; Roberton D; Jaffar S; N'Jie J; Baden L; Thompson C; Anwaruddin R; Dinan L; Glezen WP; Francis N; Fritzell B; Greenwood BM
JAMA; 1996 Apr; 275(15):1182-8. PubMed ID: 8609686
[TBL] [Abstract][Full Text] [Related]
6. Antibody responses after primary immunization in infants born to women receiving a pertussis-containing vaccine during pregnancy: single arm observational study with a historical comparator.
Ladhani SN; Andrews NJ; Southern J; Jones CE; Amirthalingam G; Waight PA; England A; Matheson M; Bai X; Findlow H; Burbidge P; Thalasselis V; Hallis B; Goldblatt D; Borrow R; Heath PT; Miller E
Clin Infect Dis; 2015 Dec; 61(11):1637-44. PubMed ID: 26374816
[TBL] [Abstract][Full Text] [Related]
7. Suboptimal Vaccination Administration in Mothers With Inflammatory Bowel Disease and Their Biologic-Exposed Infants.
Chiarella-Redfern H; Lee S; Jubran B; Sharifi N; Panaccione R; Constantinescu C; Benchimol EI; Seow CH
Inflamm Bowel Dis; 2022 Jan; 28(1):79-86. PubMed ID: 33609034
[TBL] [Abstract][Full Text] [Related]
8. Hib antibody responses in infants following diphtheria, tetanus, acellular pertussis, and conjugated Haemophilus influenzae type b (Hib) combination vaccines with decreasing amounts of tetanus toxoid.
Bernstein HH; Seyferth ER
Vaccine; 2017 Dec; 35(48 Pt B):6707-6711. PubMed ID: 29054729
[TBL] [Abstract][Full Text] [Related]
9. Safety and immunogenicity of a Haemophilus influenzae type B polysaccharide-tetanus toxoid conjugate vaccine combined with diphtheria, tetanus and pertussis vaccines in Thai infants.
Chotpitayasunondh T; Panpitpat C; Thisyakorn U; Furer E; Que JU; Hasler T; Cryz SJ
Southeast Asian J Trop Med Public Health; 1997 Mar; 28(1):91-8. PubMed ID: 9322290
[TBL] [Abstract][Full Text] [Related]
10. Delayed BCG immunization does not alter antibody responses to EPI vaccines in HIV-exposed and -unexposed South African infants.
Hesseling AC; Blakney AK; Jones CE; Esser MM; de Beer C; Kuhn L; Cotton MF; Jaspan HB
Vaccine; 2016 Jul; 34(32):3702-9. PubMed ID: 27055019
[TBL] [Abstract][Full Text] [Related]
11. Antibody responses to vaccination among South African HIV-exposed and unexposed uninfected infants during the first 2 years of life.
Reikie BA; Naidoo S; Ruck CE; Slogrove AL; de Beer C; la Grange H; Adams RC; Ho K; Smolen K; Speert DP; Cotton MF; Preiser W; Esser M; Kollmann TR
Clin Vaccine Immunol; 2013 Jan; 20(1):33-8. PubMed ID: 23114697
[TBL] [Abstract][Full Text] [Related]
12. The Effect of Maternal Peripartum Anti-TNFα Use on Infant Immune Response.
Sheibani S; Cohen R; Kane S; Dubinsky M; Church JA; Mahadevan U
Dig Dis Sci; 2016 Jun; 61(6):1622-7. PubMed ID: 26725061
[TBL] [Abstract][Full Text] [Related]
13. Vaccines in Children Exposed to Biological Agents In Utero and/or During Breastfeeding: Are They Effective and Safe?
Gisbert JP; Chaparro M
J Crohns Colitis; 2023 Jun; 17(6):995-1009. PubMed ID: 36652274
[TBL] [Abstract][Full Text] [Related]
14. Effect of antenatal parasitic infections on anti-vaccine IgG levels in children: a prospective birth cohort study in Kenya.
Malhotra I; McKibben M; Mungai P; McKibben E; Wang X; Sutherland LJ; Muchiri EM; King CH; King CL; LaBeaud AD
PLoS Negl Trop Dis; 2015 Jan; 9(1):e0003466. PubMed ID: 25590337
[TBL] [Abstract][Full Text] [Related]
15. Neonatal immunization: response to Haemophilus influenzae type b-tetanus toxoid conjugate vaccine.
Kurikka S; Käyhty H; Peltola H; Saarinen L; Eskola J; Mäkelä PH
Pediatrics; 1995 Jun; 95(6):815-22. PubMed ID: 7761204
[TBL] [Abstract][Full Text] [Related]
16. Safety and immunogenocity of a novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroups A and C-tetanus-toxoid conjugate vaccine in healthy Chinese children aged 6 months to 5 years old.
Hu JL; Tao H; Li JX; Dai WM; Song B; Sun JF; Liu P; Tang J; Liu WY; Wang SY; Zhu FC
Hum Vaccin Immunother; 2015; 11(5):1120-8. PubMed ID: 25833163
[TBL] [Abstract][Full Text] [Related]
17. Maternal HIV infection and antibody responses against vaccine-preventable diseases in uninfected infants.
Jones CE; Naidoo S; De Beer C; Esser M; Kampmann B; Hesseling AC
JAMA; 2011 Feb; 305(6):576-84. PubMed ID: 21304083
[TBL] [Abstract][Full Text] [Related]
18. Safety of Anti-TNF-Alpha Therapy During Pregnancy on Long-term Outcome of Exposed Children: A Controlled, Multicenter Observation.
Duricova D; Dvorakova E; Hradsky O; Mitrova K; Durilova M; Kozeluhova J; Kohout P; Zarubova K; Bronsky J; Hradska N; Bronska E; Adamcova M; Machkova N; Hruba V; Bortlik M; Lukas M; Malickova K; Lukas M
Inflamm Bowel Dis; 2019 Mar; 25(4):789-796. PubMed ID: 30239799
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity and safety of four different doses of Haemophilus influenzae type b-tetanus toxoid conjugated vaccine, combined with diphtheria-tetanus-pertussis vaccine (DTP-Hib), in Indonesian infants.
Punjabi NH; Richie EL; Simanjuntak CH; Harjanto SJ; Wangsasaputra F; Arjoso S; Rofiq A; Prijanto M; Julitasari ; Yela U; Herzog C; Cryz SJ
Vaccine; 2006 Mar; 24(11):1776-85. PubMed ID: 16303216
[TBL] [Abstract][Full Text] [Related]
20. Immunological effect of administration of sequential doses of Haemophilus influenzae type b and pneumococcal conjugate vaccines in the same versus alternating limbs in the routine infant immunisation schedule: an open-label randomised controlled trial.
Iro MA; Khatami A; Marshall AS; Pace D; Voysey M; McKenna J; Campbell D; Attard-Montalto S; Finn A; White C; Faust SN; Kent A; Heath PT; MacLeod E; Stanford E; Findlow H; Almond R; Bai X; Borrow R; Snape MD; Pollard AJ
Lancet Infect Dis; 2015 Feb; 15(2):172-80. PubMed ID: 25577661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
